What is Savara Price-to-Operating-Cash-Flow?
As of today (2024-12-12), Savara's share price is $3.395.
Savara's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.42. Hence, Savara's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Savara's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Savara's highest Price-to-Operating-Cash-Flow Ratio was 6.57. The lowest was 0.49. And the median was 1.78.
Savara's Cash Flow from Operations per share for the
three
months ended in Sep. 2024 was $-0.11.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.42.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 22.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 29.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 35.80% per year.
During the past 13 years, Savara's highest 3-Year average Operating Cash Flow per Share Growth Rate was 58.20% per year. The lowest was -47.00% per year. And the median was 34.90% per year.
Savara Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Savara's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Savara Price-to-Operating-Cash-Flow Chart
|
Savara Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
- |
- |
|
Savara Quarterly Data
|
|
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Savara's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Savara's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savara's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Savara's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Savara's Price-to-Operating-Cash-Flow falls into.
Savara Price-to-Operating-Cash-Flow Calculation
Savara's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 3.395 | / | -0.42 |
| = | |
Savara's Share Price of today is $3.395.
Savara's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Savara Business Description
Traded in Other Exchanges
Address
1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 78746
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Executives
| Joseph S Mccracken |
director |
C/O NEXVET BIOPHARMA PLC, NATL INST, FOSTERS AVENUE, MOUNT MERRION, BLACKROCK L2 00000 |
| David A Ramsay |
director |
HALOZYME THERAPEUTICS, INC., 11588 SORRENTO VALLEY ROAD, #17, SAN DIEGO CA 92121 |
| Matthew Pauls |
director |
9 DEER PARK DRIVE, SUITE C, MONMOUTH JUNCTION NJ 08852 |
| David L Lowrance |
officer: Chief Financial Officer |
422 WILLIAM WALLACE DRIVE, FRANKLIN TN 37064 |
| Nevan C Elam |
director |
C/O NEKTAR THERAPEUTICS, 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
| Rick Yang |
10 percent owner |
2855 SAND HILL ROAD, MENLO PARK CA 94025 |
| Scott D Sandell |
10 percent owner |
|
| Forest Baskett |
10 percent owner |
|
| Florence Anthony A. Jr. |
10 percent owner |
5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815 |
| Ali Behbahani |
10 percent owner |
5425 WISCONSIN AVE, CHEVY CHASE MD 20815 |
| Mohamad Makhzoumi |
10 percent owner |
2855 SAND HILL ROAD, MENLO PARK CA 94025 |
| Paul Edward Walker |
10 percent owner |
1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
| Carmen Chang |
10 percent owner |
2855 SAND HILL ROAD, MENLO PARK CA 94025 |
| Growth Equity Opportunities 17, Llc |
10 percent owner |
1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
| Edward T Mathers |
10 percent owner |
C/O MEDIMMUNE, INC., ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SVRA has been successfully added to your